High systolic blood pressure (SBP) remains the major cause of premature death globally despite advances in pharmacological treatment.1 2 The global direct medical costs associated with hypertension treatment are estimated at $370 billion/year worldwide, with the healthcare savings from effective management of this condition projected at about $100 billion/year.3 Unfortunately, relatively little attention is given to non-pharmacological strategies, including structured exercise interventions. A recent network meta-analysis of randomised controlled trials (RCTs) published in the BJSM4 aimed to compare the effects of exercise interventions and medications on SBP. We highlight the key findings of this network meta-analysis that are particularly relevant for clinical practice and health policy. The study included 391 RCTs (39,742 …

中文翻译：

---

信息图表。运动治疗与抗高血压药物相比如何？

尽管药物治疗取得了进步，但高收缩压 (SBP) 仍然是全球过早死亡的主要原因。 1 2 全球与高血压治疗相关的直接医疗费用估计为 3700 亿美元/年，有效管理可节省医疗保健费用预计每年约 1000 亿美元。3 不幸的是，对非药物策略的关注相对较少，包括结构化的运动干预。最近发表在 BJSM4 上的随机对照试验 (RCT) 网络荟萃分析旨在比较运动干预和药物对 SBP 的影响。我们强调了与临床实践和卫生政策特别相关的网络荟萃分析的主要发现。该研究包括 391 项 RCT（39,742 …